Disparate kinetics in immune response of two different <i>Haemophilus influenzae</i> type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule-Reference-Cited by-同舟云学术

Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule

Published:2024-04-30 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Martinón-Torres Federico¹²³^ORCID,Salamanca de la Cueva Ignacio⁴^ORCID,Horn Michael⁵^ORCID,Westerholt Soeren⁶,Bosis Samantha⁷^ORCID,Meyer Nadia⁸^ORCID,Cheuvart Brigitte⁸^ORCID,Virk Navpreet⁹^ORCID,Jakes Rupert W.¹⁰^ORCID,Duchenne Maurine⁸^ORCID,Van den Steen Peter⁸^ORCID

Affiliation:

1. Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

2. Genetics, Vaccines and Infectious Diseases Research Group (GENvip), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

3. Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain

4. Instituto Hispalense de Pediatría, Sevilla, Spain

5. Praxis Dr. med. Michael Horn, Bayern, Schoenau am Koenigssee, Germany

6. Praxis für Kinder und Jugendmedizin Drs. Westerholt/Matyas, Wolfsburg, Germany

7. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy

8. GSK, Wavre, Belgium

9. GSK, Mumbai, India

10. GSK, London, UK

Funder

GlaxoSmithKline

Publisher

Informa UK Limited